相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation
Rajib Shome et al.
CELLULAR ONCOLOGY (2021)
Triple-negative breast cancer: understanding Wnt signaling in drug resistance
Parnaz Merikhian et al.
CANCER CELL INTERNATIONAL (2021)
A comprehensive review on time-tested anticancer drug doxorubicin
Sruthi Sritharan et al.
LIFE SCIENCES (2021)
Selenium sulfide disrupts the PLAGL2/C-MET/STAT3-induced resistance against mitochondrial apoptosis in hepatocellular carcinoma
Tianfeng Yang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1
Liang Wu et al.
THERANOSTICS (2021)
PLAGL2 promotes epithelial-mesenchymal transition and mediates colorectal cancer metastasis via β-catenin-dependent regulation of ZEB1
Liang Wu et al.
BRITISH JOURNAL OF CANCER (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Advancing Cancer Research and Medicine with Single-Cell Genomics
Bora Lim et al.
CANCER CELL (2020)
Overcoming Endocrine Resistance in Breast Cancer
Ariella B. Hanker et al.
CANCER CELL (2020)
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xiufang Xu et al.
MOLECULAR CANCER (2020)
APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells
Casey D. Stefanski et al.
NEOPLASIA (2019)
Aptamer selection and applications for breast cancer diagnostics and therapy
Mei Liu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2017)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Precision medicine for metastatic breast cancer-limitations and solutions
Monica Arnedos et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Epithelial-to-mesenchymal transition: What is the impact on breast cancer stem cells and drug resistance
Paraskevi Mallini et al.
CANCER TREATMENT REVIEWS (2014)
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial
John R. Mackey et al.
LANCET ONCOLOGY (2013)
Expression of Wnt3 Activates Wnt/β-Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells
Yanyuan Wu et al.
MOLECULAR CANCER RESEARCH (2012)